Erschienen in:

01.05.2007 | Research Articles

Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study

verfasst von: L. G. Estévez, P. Sánchez-Rovira, M. Dómine, A. León, I. Calvo, A. Jaén, V. Casado, G. Rubio, M. Díaz, C. Miró, F. Lobo, E. Carrasco, M. Casillas, B. San Antonio

Erschienen in: Clinical and Translational Oncology | Ausgabe 5/2007